Literature DB >> 1271526

Message activity of influenza viral RNA.

P Tekamp, E E Penhoet.   

Abstract

The message activity of influenza virion RNA in the wheat germ cell-free protein-synthesizing system was investigated. RNA extracted from purified virions was found to direct the synthesis of a polypeptide that had the mobility of viral nucleocapsid protein on sodium dodecyl sulfate-polyacrylamide gels. Further characterization of the protein indicated it was not the nucleocapsid protein. No other polypeptides were detected. We conclude that influenza virion RNA is inactive as a template for the synthesis of virus-specific proteins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1271526      PMCID: PMC515614          DOI: 10.1128/JVI.18.2.812-816.1976

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Influenza virus messenger ribonucleoprotein.

Authors:  M W Pons
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Translation of reovirus mRNA, poliovirus RNA and bacteriophage Qbeta RNA in cell-free extracts of mammalian cells.

Authors:  L Villa-Komaroff; M McDowell; D Baltimore; H F Lodish
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

3.  RNA-dependent RNA polymerase activity associated with virions and subviral particles of myxoviruses.

Authors:  N L Chow; R W Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

4.  Cell-free transfer of leucine by transfer ribonucleic acid from mouse liver and plasma cell tumors into rabbit hemoglobin.

Authors:  J F Mushinski; A Galizzi; G von Ehrenstein
Journal:  Biochemistry       Date:  1970-02-03       Impact factor: 3.162

5.  Isolation of eukaryotic messenger RNA on cellulose and its translation in vitro.

Authors:  G Schutz; M Beato; P Feigelson
Journal:  Biochem Biophys Res Commun       Date:  1972-11-01       Impact factor: 3.575

6.  Cell-free hemoglobin synthesis. II. Characteristics of the transfer ribonucleic acid-dependent assay system.

Authors:  J M Gilbert; W F Anderson
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

7.  Transcription of the influenza ribonucleic acid genome by a virion polymerase. 3. Completeness of the transcription process.

Authors:  D H Bishop; P Roy; W J Bean; R W Simpson
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

8.  Isolation of influenza virus ribonucleoprotein from infected cells. Demonstration of the presence of negative-stranded RNA in viral RNP.

Authors:  M W Pons
Journal:  Virology       Date:  1971-10       Impact factor: 3.616

9.  Studies on the replication of influenza virus RNA.

Authors:  M W Pons
Journal:  Virology       Date:  1972-03       Impact factor: 3.616

10.  Direct evidence for messenger activity of influenza virion RNA.

Authors:  W Siegert; G Bauer; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

View more
  5 in total

1.  Phosphorylated protein component present in influenza virions.

Authors:  M L Privalsky; E E Penhoet
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

2.  Cell-free coupling of influenza virus RNA transcription and translation.

Authors:  J Content; L D Wit; M Horisberger
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

3.  P1 and P3 proteins of influenza virus are required for complementary RNA synthesis.

Authors:  P Palese; M B Ritchey; J L Schulman
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

4.  Preparation of projection-less particles from influenza virus and their messenger activities in prokaryotic and eukaryotic systems.

Authors:  E N Arida; T Hultin
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis.

Authors:  M L Privalsky; E E Penhoet
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.